60 Degrees Pharma announces 1-for-4 reverse stock split; shares up
Source: SeekingAlpha
2026-01-15 08:16:11 ET
More on 60 Degrees Pharmaceuticals
- 60 Degrees Pharmaceuticals GAAP EPS of -$0.66 misses by $0.20, revenue of $0.44M beats by $0.29M
- Seeking Alpha’s Quant Rating on 60 Degrees Pharmaceuticals
- Historical earnings data for 60 Degrees Pharmaceuticals
- Financial information for 60 Degrees Pharmaceuticals
Read the full article on Seeking Alpha
For further details see:
60 Degrees Pharma announces 1-for-4 reverse stock split; shares up
60 Degrees Pharmaceuticals Inc.
NASDAQ: SXTP
SXTP Trading
-1.43% G/L:
$2.07 Last:
33,601 Volume:
$2.03 Open:
SXTP Latest News
February 02, 2026 08:01:00 am
60 Degrees Pharmaceuticals Expands Access to ARAKODA® with GoodRx Partnership
January 28, 2026 08:01:00 am
60 Degrees Pharmaceuticals Exercises License Option with Florida State University for Large-Scale Purification of Castanospermine for Non-Rx Use
January 22, 2026 08:01:00 am
60 Degrees Pharmaceuticals Announces Partnership with Runway Health to Provide International Travelers Direct Access to ARAKODA® for Malaria Prevention
January 15, 2026 08:01:00 am
60 Degrees Pharmaceuticals, Inc. Announces Approval of Reverse Stock Split Ratio
SXTP Stock Data
$4,283,329
1,039,738
1.41%
1
N/A
Biotechnology & Life Sciences
Healthcare
US
Washington
